Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05388708 · ClinicalTrials.gov registry record
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
A clinical trial of Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation, sponsored by University of Michigan.
- Recruiting
- Registry status
- 550
- Enrollment target
- 20
- Study locations
NCT05388708 is a study of Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 550 participants, above the 350-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (57% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT05388708, a study of Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 20
- Study locations
Study Summary
ASCEND researchers are partnering with families of children who receive extracorporeal membrane oxygenation (ECMO) after a sudden failure of breathing named pediatric acute respiratory distress syndrome (PARDS). ECMO is a life support technology that uses an artificial lung outside of the body to do the lung's work. ASCEND has two objectives. The first objective is to learn more about children's abilities and quality of life among ECMO-supported children in the year after they leave the pediatric intensive care unit. The second objective is to compare short and long-term patient outcomes in two groups of children: one group managed with a mechanical ventilation protocol that reserves the use of extracorporeal membrane oxygenation (ECMO) until protocol failure to another group supported on ECMO per usual care.
Conditions Studied
Interventions
- DEVICE ECMO support
- OTHER PROSpect protocolized therapies
Study Locations (20)
California
- Loma Linda University Children's Hospital - Loma Linda
- UCLA Mattel Children's Hospital - Los Angeles
- Valley Children's Hospital - Madera
- UCSF Benioff Children's Hospital Oakland - Oakland
- Children's Hospital of Orange County - Orange
- Lucile Packard Children's Hospital Stanford - Palo Alto
- UCSF Benioff Children's Hospital - San Francisco - San Francisco
Florida
- UF Health Shands Children's Hospital - Gainesville
- Nicklaus Children's Hospital - Miami
- Orlando Health Arnold Palmer Hospital for Children - Orlando
- Nemours Children's Hospital, Florida - Orlando
Connecticut
- Connecticut Children's Medical Center - Hartford
- Yale New Haven Children's Hospital - New Haven
Alabama
- Children's of Alabama - Birmingham
Arizona
- Phoenix Children's Hospital - Phoenix
Arkansas
- Arkansas Children's Hospital - Little Rock
Colorado
- Children's Hospital Colorado - Aurora
Delaware
- Nemours Children's Hospital, Delaware - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2021-02-04 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05388708
The ClinicalTrials.gov registry entry for NCT05388708 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 350-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (57% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Respiratory Distress Syndrome appearing as the primary indexed condition, and to 2 interventions - of which ECMO support is the first listed.
NCT05388708 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05388708 about?
NCT05388708 is a clinical study titled "ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)". ASCEND researchers are partnering with families of children who receive extracorporeal membrane oxygenation (ECMO) after a sudden failure of breathing named pediatric acute respiratory distress syndrome (PARDS). ECMO is a life support technology that uses an artificial lung outside of the body to do...
What is the current status of trial NCT05388708?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2021-02-04. Estimated completion is 2027-09-30.
What conditions does trial NCT05388708 study?
This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation.
What interventions are being tested in trial NCT05388708?
The interventions under investigation include: ECMO support (DEVICE), PROSpect protocolized therapies (OTHER).
Who is sponsoring clinical trial NCT05388708?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05388708 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Distress Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RECRUITING · Phase 2
-
The ARISE Study - Use of Vertical Positioning
RECRUITING · NA
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RECRUITING · Phase 2
-
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
RECRUITING · Phase 3
-
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
RECRUITING · NA
-
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
RECRUITING
Explore more on PlainTrial
Acute Respiratory Distress Syndrome
All registered trials for this condition
Extracorporeal Membrane Oxygenation
All registered trials for this condition
Alabama
All trials with a study site in Alabama
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.